A Retrospective Study Of The Efficacy Of Minimally Invasive Treatment And Minimally Invasive Combined With Xingnaojing In The Acute Phase Of Cerebral Hemorrhage

BACKGROUND: Hemorrhagic stroke is a neurological emergency and progresses rapidly.The timely and effective diagnosis and treatment of the acute stage is directly related to the prognosis of the patient.Promoting hematoma absorption and preventing further progress of cerebral hemorrhage is the key to the treatment of acute stage of cerebral hemorrhage.With the continuous development of minimally invasive techniques,minimally invasive surgery for the treatment of cerebral hemorrhage is gradually emerging,and has become a clinically recognized treatment.This treatment method can remove most of the hematoma,effectively relieve high intracranial pressure,and has less trauma.However,minimally invasive treatment has a strict time window and indications,and treatment costs and later rehabilitation costs are still relatively high.In recent years,traditional Chinese medicine injections have been favored by clinicians because of their unique advantages of rapid effect and convenient application.Xingnaojing injection,as a commonly used traditional Chinese medicine injection in clinical practice,can clear away heat and detoxify,enlighten the brain,cool the blood and promote blood circulation.It has the functions of scavenging oxygen free radicals,inhibiting inflammation,reducing cerebral edema,improving cerebral microcirculation,and inhibiting apoptosis of nerve cells.Rehabilitation of patients with cerebral hemorrhage is one of the important means of clinical treatment of cerebral hemorrhage.The treatment plan of minimally invasive surgery combined with Xingnaojing injection for the treatment of cerebral hemorrhage is gradually being promoted in the clinic,and has attracted the attention of medical workers.Objective: To study the clinical effect of minimally invasive extraction of intracranial hematoma(minimally invasive surgery)combined with Xingnaojing injection in the acute phase of hypertensive intracerebral hemorrhage,and to explore the value of Xingnaojing injection in the acute phase of cerebral hemorrhage.Methods:Through a retrospective study,72 HICH patients who met the criteria of this study and were admitted to the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine and Hunan Provincial Brain Hospital from January 2015 to January 2020 were collected.According to the different treatment methods of patients during hospitalization,they are divided into the group of conventional Western medicine combined with minimally invasive surgery combined with Xingnaojing injection(observation group)and the group of conventional Western medicine combined with minimally invasive surgery(control group).There were 35 patients in the observation group and 37 patients in the control group.Collect the amount of intracranial hematoma before and after treatment,National Institute of Health Stroke Scale(NIHSS)score,daily life ability scale score(Activity of Daily Living,ADL)changes,and clinical neurological function The recovery rate of the defect was calculated according to the efficacy evaluation standard.The statistical methods were used to analyze the data of the two groups before and after treatment and to compare the difference between the two groups before and after treatment.Results: 1.The total number of cases in the observation group of this study was 35 cases,1 case was cured,15 cases were markedly effective,18 cases were effective,1 case was ineffective,and the total effective rate was97.1%.The total number of cases in the control group was 37 cases,0 cases were cured,7 cases were markedly effective,25 cases were effective,5cases were ineffective,and the total effective rate was 86.5%.In terms of efficiency,the minimally invasive surgery combined with Xingnaojing injection group was better than the minimally invasive group(P<0.05).2.In this study,minimally invasive surgery and combined minimally invasive surgery combined with Xingnaojing injection can reduce the NIHSS score of patients with cerebral hemorrhage and improve patients' daily life ability,but the treatment of cerebral hemorrhage combined with minimally invasive surgery and Xingnaojing injection is improving nerve function The defect and improvement of daily behavioral ability are better than simple minimally invasive surgery(P<0.05).3.In this study,minimally invasive surgery and minimally invasive surgery combined with Xingnaojing injection can reduce intracranial hematoma in patients with cerebral hemorrhage,but minimally invasive surgery combined with Xingnaojing injection reduces intracranial hematoma compared with simple minimally invasive surgery.There is no clear conclusion(P>0.05).4.Complications and adverse reactions: A retrospective study was conducted on the collected data of 72 cases.One patient relapsed after the symptoms improved during the observation period,5 patients developed postoperative intracranial gas,and 1 patient had a cranial gas Internal infection,no other minimally invasive postoperative complications.One patient was complicated by cerebral infarction,and one patient died during treatment(eliminated).No adverse reactions such as rash,nausea,blushing,itching,and liver and kidney function damage were observed after infusion of Xingnaojing injection.Conclusion: Both minimally invasive surgery and minimally invasive combined with Xingnaojing injection in the treatment of acute cerebral hemorrhage can significantly improve the patient's NIHSS score and daily life ability score.The combined effect of Xingnaojing injection group is better and the patient's clinical treatment can be improved faster.Symptoms and signs can help patients recover.